dc.contributor.author | Altuntaş, Ebru | |
dc.contributor.author | Özkan, Burcu | |
dc.contributor.author | Gözütok, Kübra | |
dc.date.accessioned | 2021-03-02T17:36:58Z | |
dc.date.available | 2021-03-02T17:36:58Z | |
dc.identifier.citation | Altuntaş E., Gözütok K., Özkan B., Nanoengineering of stem cells for neural regenerative medicine, "NEURAL REGENERATIVE NANOMEDICINE", Mehdi Razavi, Editör, Elsevier Science, Oxford/Amsterdam , London, ss.156-192, 2020 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_e2483830-10e1-49fc-9570-b365cd7af2b4 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/4150 | |
dc.identifier.uri | https://www.elsevier.com/books/neural-regenerative-nanomedicine/razavi/978-0-12-820223-4 | |
dc.description.abstract | The administration of standardized exosomes secreted from stem cells under specific culture conditions and/or exosomes derived from stem cells designed to carry desired miRNAs, mRNAs, and proteins is promising for the treatment of many neurodegenerative diseases. However various barriers must be overcome before exosomes are applied in the clinic. For this reason, it is necessary to find a suitable method for the purification of exosomes that is scalable, compliant with CGMP guidelines, does not change the biological activity of them, and is effective to provide a homogeneous population of exosomes containing similar miRNAs, proteins, and lipids. | |
dc.language.iso | eng | |
dc.publisher | Elsevier Science, Oxford/Amsterdam | |
dc.subject | Eczacılık | |
dc.subject | Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | |
dc.subject | Life Sciences | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Klinik Tıp (MED) | |
dc.title | NEURAL REGENERATIVE NANOMEDICINE | |
dc.type | Kitapta Bölüm | |
dc.contributor.department | İstanbul Üniversitesi , Eczacılık Fakültesi , Eczacılık | |
dc.contributor.firstauthorID | 2496441 | |